Philip Watson MB MSc FRCP FFPM
Frankfurt Am Main Area, Germany
Head, Risk Management Office at Boehringer Ingelheim
Pharmaceuticals
Education
St Mary's Hospital Medical School, Imperial College, London 1981 — 1986
MBBS, Medicine
Experience
Boehringer Ingelheim January 2015 - Present
Novartis Pharma AG August 2013 - November 2014
Roche Products Ltd November 2010 - April 2013
Roche Products Ltd May 2009 - October 2010
Roche Pharmaceuticals February 2006 - May 2009
Alleyn Healthcare Consulting 2004 - 2006
Exprimo Consulting 2002 - 2004
Pharsight Corporation 1999 - 2002
SmithKline Beecham P 1993 - 1999
Skills
Regulatory Submissions, GCP, Drug Development, Pharmaceutical Industry, Biotechnology, Immunology, Safety Management..., ICH-GCP, Regulatory Affairs, Biopharmaceuticals, Life Sciences, Translational Medicine, Infectious Diseases, Vaccines, Medical Writing, Clinical Monitoring, Drug Safety, Drug Discovery, Clinical Data Management, CRO, EDC, Clinical Research, Pharmaceutics, Therapeutic Areas, Clinical Trials, Clinical Pharmacology, Patient Safety, Diabetes, Strategic Planning, Protocol, Medical Affairs, Neurology, Biomarkers, Pharmacology, Regulatory Requirements, Pharmacovigilance, MedDRA, Hematology, Lifesciences, Oncology, Educational Leadership, Clinical Development, safety risk management, Biostatistics